# Phase 5 - Review: issue-46

## Code Review Findings

### CRITICAL
none

### HIGH
none

### MEDIUM/LOW
none — all code quality checks passed; naming consistent; scope compliance confirmed

## Security Review
ran: no — prose-only change; no auth, payments, user data, filesystem access, external API calls, or secrets touched

### Findings
N/A — file-risk scan shows only markdown, shell, and JavaScript validator files with no security-sensitive surface

## Required Agent Compliance
| Requirement | Status | Evidence | Skip Reason |
|-------------|--------|----------|-------------|
| code-reviewer | invoked | .cache/code-reviewer.md | |
| security-reviewer | N/A | prose-only; no security-sensitive files touched | no auth/payments/user-data/secrets |
| review-fix executors | N/A | .cache/review-fix-*.md | no CRITICAL/HIGH findings |
| advisor critical gate | N/A | no CRITICAL findings | |

## Fixes Applied
none — no CRITICAL or HIGH issues

## Validation Evidence
All 4 validators pass (exit 0):
- `node scripts/validate-script-sync.js` — OK: 7 common scripts in sync
- `node scripts/validate-workflow-contracts.js` — Workflow contract validation passed
- `node scripts/validate-kaola-workflow-contracts.js` — Kaola-Workflow contract validation passed
- `node scripts/simulate-workflow-walkthrough.js` — Workflow walkthrough simulation passed

## Follow-Up Items
- Pre-existing regression in `plugins/kaola-workflow/scripts/simulate-kaola-workflow-walkthrough.js`: this script is currently byte-identical to the Claude variant (scripts/simulate-workflow-walkthrough.js) due to a prior sync. The Codex-specific test suite (originally ~1100 lines) was lost. Restoring the full Codex walkthrough is deferred to a future issue.
- MEDIUM: The Startup Step 3 change in workflow-next.md leaves a subtle gap: it tells agents to ask the user if no target is known, but doesn't explicitly say to re-run Startup Step 0 agent selection logic first. This is fine for the current trust model but could be clarified in a follow-up.

## Review Status
PASSED
